DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

37 Drugs in Development

37 Drugs in Development

DIGITAL CONTENT

11 NEWS #PharmaBuzz

media
11 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

37DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Crv431, Cpi-431, Crv-431, Cpi-431-32, Rencofilstat [usan], M3h4d91ay5

Molecular Formula

C₆₇H₁₂₂N₁₂O₁₃

Molecular Weight

1303.8 g/mol

InChI Key

KBARHGHBFILILC-NGIJKBHDSA-N

FDA UNII

M3H4D91AY5

1 2D Structure

Rencofilstat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(7R,8R)-8-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,10,16,20,23,25,28,31-decamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]acetamide

2.1.2 InChI

InChI=1S/C67H122N12O13/c1-26-48-63(88)73(19)46(17)62(87)74(20)50(34-38(4)5)59(84)72-53(41(10)11)66(91)75(21)49(33-37(2)3)58(83)69-44(15)57(82)70-45(16)61(86)76(22)51(35-39(6)7)64(89)77(23)52(36-40(8)9)65(90)78(24)54(42(12)13)67(92)79(25)55(60(85)71-48)56(81)43(14)31-29-27-28-30-32-68-47(18)80/h37-46,48-56,81H,26-36H2,1-25H3,(H,68,80)(H,69,83)(H,70,82)(H,71,85)(H,72,84)/t43-,44+,45-,46-,48+,49+,50+,51+,52+,53+,54+,55+,56-/m1/s1

2.1.3 InChI Key

KBARHGHBFILILC-NGIJKBHDSA-N

2.1.4 Canonical SMILES

CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CCCCCCNC(=O)C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C

2.1.5 Isomeric SMILES

CC[C@H]1C(=O)N([C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)CCCCCCNC(=O)C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C

2.2 Other Identifiers

2.2.1 UNII

M3H4D91AY5

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Crv-431

2. Crv431

3. N-((7r,8r)-8-((2s,5s,8r,11s,14s,17s,20s,23r,26s,29s,32s)-5-ethyl-11,17,26,29-tetraisobutyl-14,32-diisopropyl-1,7,8,10,16,20,23,25,28,31-decamethyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl)-8-h

2.3.2 Depositor-Supplied Synonyms

1. Crv431

2. Cpi-431

3. Crv-431

4. Cpi-431-32

5. Rencofilstat [usan]

6. M3h4d91ay5

7. 1383420-08-3

8. Rencofilstat [inn]

9. Unii-m3h4d91ay5

10. Cpi431

11. Chembl4297487

12. Gtpl11612

13. Who 11781

14. 6-((2s,3r,4r)-10-acetamido-3-hydroxy-4-methyl-2-(methylamino)decanoic Acid)-8-(n-methyl-dalanine)cyclosporin A; 1,11-anhydro(l-alanyl-d-alanyl-n-methyl-l-leucyl-n-methyl-l-leucyl-n-methyl-l-valyl-(3r,4r)-10-acetamido-3-hydroxyn,4-dimethyl-l-2-aminodecanoyl-l-2-aminobutanoyl-nmethyl-d-alanyl-n-methyl-l-leucyl-l-valyl-n-methyl-l-leucine)

15. Cyclosporin A, 6-((2s,3r,4r)-10-(acetylamino)-3-hydroxy-4-methyl-2-(methylamino)decanoic Acid)-8-(n-methyl-d-alanine)-

16. N-((7r,8r)-8-((2s,5s,8r,11s,14s,17s,20s,23r,26s,29s,32s)-5-ethyl-11,17,26,29-tetraisobutyl-14,32-diisopropyl-1,7,8,10,16,20,23,25,28,31-decamethyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl)-8-h

17. N-((7r,8r)-8-((2s,5s,8r,11s,14s,17s,20s,23r,26s,29s,32s)-5-ethyl-11,17,26,29-tetraisobutyl-14,32-diisopropyl-1,7,8,10,16,20,23,25,28,31-decamethyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl)-8-hydroxy-7-methyloctyl)acetamide

18. N-[(7r,8r)-8-[(2s,5s,8r,11s,14s,17s,20s,23r,26s,29s,32s)-5-ethyl-1,7,8,10,16,20,23,25,28,31-decamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl]-8-hydroxy-7-methyloctyl]acetamide

19. N-[(7r,8r)-8-[(2s,5s,8r,11s,14s,17s,20s,23r,26s,29s,32s)-5-ethyl-1,7,8,10,16,20,23,25,28,31-decamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-8-hydroxy-7-methyloctyl]acetamide

2.4 Create Date

2018-09-09

3 Chemical and Physical Properties

Molecular Formula	C₆₇H₁₂₂N₁₂O₁₃
Molecular Weight	1303.8 g/mol
XLogP3	8.1
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	13
Rotatable Bond Count	20
Exact Mass	1302.92543199 g/mol
Monoisotopic Mass	1302.92543199 g/mol
Topological Polar Surface Area	308 Å²
Heavy Atom Count	92
Formal Charge	0
Complexity	2490
Isotope Atom Count	0
Defined Atom Stereocenter Count	13
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1